MENA

  • Blood test help personalise depression treatment

    A new blood test aims to improve depression treatment by matching patients to antidepressants more likely to work. The test can evaluate how a patient’s brain will respond to different antidepressants without the patient having to take them first. Depression treatment still often relies on trial and error, with patients trying several medicines [...]

  • €4.8m EU-funded AI project to tackle child diarrhoeal disease in Africa

    An AI tool to tackle diarrhoeal disease in children under five in sub-Saharan Africa is being developed with €4.8m in EU funding. The CARE-AFRICA project aims to create a tool that can predict the most likely pathogen responsible for a child's diarrhoeal disease and provide guidance on the most effective treatment options based on that [...]

  • Live forever – special report on the future of longevity

    What does healthy lifespan look like, and how long can it last? A new special report from our sister publication Agetech World explores the ‘biohacking’ quest to re-engineer ageing - and who it could benefit. Read the report in full below.

  • Metabolic disease, misaligned incentives, and what I learnt at WHX Dubai

    By James Hounsell, Co-founder, Evolene Over the past few months, I’ve spent more time working across the Middle East than ever before. It’s been a steep learning curve, in the best way. Cultural differences are the obvious part, but the more meaningful differences are structural: how healthcare is organised, how decisions get made, what’s funded, [...]

  • Pharmaceutical Press to raise awareness of global medication safety at WHX Dubai 2026

    Pharmaceutical Press, the knowledge business of the Royal Pharmaceutical Society, will attend WHX Dubai 2026 to shine a spotlight on one of the most pressing - yet preventable - threats to patient safety worldwide: medication errors. At WHX Dubai 2026, Pharmaceutical Press will demonstrate how its evidence-based pharmaceutical knowledge supports confident decisions about the safe [...]

  • Health Innovation Network to showcase UK innovators at WHX Dubai 2026

    Some of the UK’s most exciting HealthTech SMEs will be showcased on the Health Innovation Network Zone at World Health Expo (WHX) Dubai 2026, as the cohort of companies is heading to the Middle East’s largest healthcare event. Bringing together more than 131,000 attendees, 40 international pavilions, and 3,600+ exhibitors from 191 countries, WHX Dubai [...]

  • Amorphical enrols first patient in Phase 2 trial for stage IV pancreatic cancer

    Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, today announced that the first patient has been enrolled in its Phase 2 clinical trial evaluating the company’s investigational nano-amorphous mineral-based therapy in patients with Stage IV pancreatic cancer. The study, approved by the Helsinki Committee of Shaare Zedek Medical Center and the Israel Ministry [...]

  • Healthcare London signs landmark partnership with CF to advance UK–Saudi healthcare collaboration

    Healthcare London, a collaboration of the capital’s leading private healthcare providers and NHS teaching hospitals, has signed a landmark partnership with CF (Carnall Farrar) to deepen UK–Saudi healthcare collaboration and expand Saudi patients’ access to London’s world-class medical expertise. The partnership builds on the longstanding relationship between the United Kingdom and the Kingdom of Saudi [...]

  • Healthcare London signs landmark partnership with CF

    Healthcare London has signed a landmark partnership with CF (Carnall Farrar) to deepen UK-Saudi healthcare collaboration and expand Saudi patients’ access to London’s world-class medical expertise. The partnership builds on the longstanding relationship between the United Kingdom and the Kingdom of Saudi Arabia and aligns directly with Saudi Vision 2030, supporting the Kingdom’s ambition to [...]

  • ABHI expands global platform for UK health tech at WHX Dubai 2026

    The Association of British HealthTech Industries (ABHI) has unveiled a new initiative designed to strengthen international partnerships and boost the global presence of UK health technology companies at WHX Dubai 2026 - one of the world’s largest and most influential healthcare trade shows. New for 2026, ABHI will introduce the UK Networking Zone - a [...]